Gemcitabine: Efficacy in the Treatment of Advanced Stage Nonsquamous Non-Small Cell Lung Cancer

por Hayashi, Hidetoshi, Kurata, Takayasu, Nakagawa, Kazuhiko
Publicado 2011

Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?

por Haratani, Koji, Hayashi, Hidetoshi, Nakagawa, Kazuhiko
Publicado 2020

Real-World Clinical Outcomes after Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer

por Olsen, Steven, Liao, Jiemin, Hayashi, Hidetoshi
Publicado 2022

Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidence

por Togashi, Yosuke, Hayashi, Hidetoshi, Nakagawa, Kazuhiko, Nishio, Kazuto
Publicado 2014

N-acetylneuraminic acid coupled human recombinant TNFα exhibits enhanced anti-tumor activity against Meth-A fibrosarcoma and reduced toxicity

por Hayashi, Akiko, Hayashi, Hidetoshi, Chiba, Taku, Sasayama, Satoshi, Onozaki, Kikuo
Publicado 2006

HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ

por Miyajima, Chiharu, Hayakawa, Yurika, Inoue, Yasumichi, Nagasaka, Mai, Hayashi, Hidetoshi
Publicado 2022

Real-World Data About Treatment Outcomes for Patients with EGFR-Mutated NSCLC Resistance to Osimertinib and Platinum-Based Chemotherapy

por Hayashi, Hidetoshi, Nishio, Makoto, Takahashi, Michiko, Tsuchiya, Hiroaki, Kasahara-Kiritani, Mami
Publicado 2023

Efficacy of Crizotinib After Entrectinib Resistance Due to MET Polysomy in ROS1-Rearranged NSCLC: A Case Report

por Takakura, Toshiaki, Kanemura, Hiroaki, Sakai, Kazuko, Nishio, Kazuto, Nakagawa, Kazuhiko, Hayashi, Hidetoshi
Publicado 2023

Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumab

por Kato, Ryoji, Hayashi, Hidetoshi, Tanizaki, Junko, Tanaka, Kaoru, Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado 2017

Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFR

por Sakai, Hitomi, Hayashi, Hidetoshi, Iwasa, Tsutomu, Hasegawa, Yoshikazu, Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado 2017

Treatment of EGFR mutation–positive non–small cell lung cancer complicated by Trousseau syndrome with gefitinib followed by osimertinib: a case report

por Nonagase, Yoshikane, Takeda, Masayuki, Tanaka, Kaoru, Hayashi, Hidetoshi, Iwasa, Tsutomu, Nakagawa, Kazuhiko
Publicado 2018

Glycosylated human interleukin-1α, neoglyco IL-1α, coupled with N-acetylneuraminic acid exhibits selective activities in vivo and altered tissue distribution

por Sasayama, Satoshi, Moriya, Kayoko, Chiba, Taku, Matsumura, Takayuki, Hayashi, Hidetoshi, Hayashi, Akiko, Onozaki, Kikuo
Publicado 2000

Insights into Regulators of p53 Acetylation

por Nagasaka, Mai, Miyajima, Chiharu, Aoki, Hiromasa, Aoyama, Mineyoshi, Morishita, Daisuke, Inoue, Yasumichi, Hayashi, Hidetoshi
Publicado 2022

Synergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell lines

por Terashima, Masato, Sakai, Kazuko, Togashi, Yosuke, Hayashi, Hidetoshi, De Velasco, Marco A, Tsurutani, Junji, Nishio, Kazuto
Publicado 2014

TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription

por Kawarada, Yuki, Inoue, Yasumichi, Kawasaki, Fumihiro, Fukuura, Keishi, Sato, Koichi, Tanaka, Takahito, Itoh, Yuka, Hayashi, Hidetoshi
Publicado 2016

A Case of Pulmonary Tumor Thrombotic Microangiopathy Suggested by the Presence of Tumor Cells in Peripheral Blood

por Kawanaka, Yusuke, Kawakami, Hisato, Shimizu, Shigeki, Yoshida, Takeshi, Hayashi, Hidetoshi, Nishio, Kazuto, Satou, Takao, Nakagawa, Kazuhiko
Publicado 2020

Phase 1 study of new formulation of patritumab (U3-1287) Process 2, a fully human anti-HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non...

por Shimizu, Toshio, Yonesaka, Kimio, Hayashi, Hidetoshi, Iwasa, Tsutomu, Haratani, Koji, Yamada, Hironori, Ohwada, Shoichi, Kamiyama, Emi, Nakagawa, Kazuhiko
Publicado 2017

Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of EGFR or HER2

por Takeda, Masayuki, Sakai, Kazuko, Hayashi, Hidetoshi, Tanaka, Kaoru, Tanizaki, Junko, Takahama, Takayuki, Haratani, Koji, Nishio, Kazuto, Nakagawa, Kazuhiko
Publicado 2018

Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence

por Miyajima, Chiharu, Kawarada, Yuki, Inoue, Yasumichi, Suzuki, Chiaki, Mitamura, Kana, Morishita, Daisuke, Ohoka, Nobumichi, Imamura, Takeshi, Hayashi, Hidetoshi
Publicado 2020

Anti-Inflammatory Activity of Kurarinone Involves Induction of HO-1 via the KEAP1/Nrf2 Pathway

por Nishikawa, Sakiko, Inoue, Yasumichi, Hori, Yuka, Miyajima, Chiharu, Morishita, Daisuke, Ohoka, Nobumichi, Hida, Shigeaki, Makino, Toshiaki, Hayashi, Hidetoshi
Publicado 2020